Donate and receive a tax benefit. Clinical trials will be underway in 2022 for a new therapeutic drug combination, which could improve the long-term survival of children with high risk neuroblastoma. You can be a part of it. Read more
New treatment research is underway at the Children’s Cancer Institute which could improve the long-term survival of children with high risk neuroblastoma. You can be a part of it. Read more
Take a look at the appeals we are currently raising funds for below. You can choose to donate or you can set up your own fundraising page.
Help us beat the number one toddler cancer. Please donate today to support world class Australian research into developing better, safer treatments. Read more
Support vital world class Australian neuroblastoma research, where the need is greatest to help find better, kinder and safer treatments. Read more
Brighten a child's day - for as little as $59, you can gift a child with neuroblastoma a fun Activity Pack to keep them entertained and engaged whilst isolated indoors at home or in hospital. Read more
Venetoclax is a promising drug currently in trial for a number of cancers, including neuroblastoma BUT in combination with another agent we think it'll perform even better. Dr Jamie Fletcher from the Children's Cancer Institute needs funding to identify these combinations. Thank you for making this happen! Read more